Kallyope
Focusing on Big Health Challenges That Matter
- Headquarters
- New York, New York
- Employees
- 51–200
- Founded
- 2015
- Business Model
- B2B
- Website
- kallyope.com
- Total Funding
- $487.2M
- Last Round
- $8.2M GrantMay 2023
About
Founded in 2015 by world-leading neuroscientists, Kallyope uses its Klarity platform to target the gut-brain axis for neurological and metabolic diseases. The late-stage pipeline includes acute migraine treatments and novel metabolism programs entering clinical studies in 2026.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Create Free AccountFunding History
Sign up to view funding details
Create a free account to see full funding history, valuations, and investor participation.
Create Free Account